Dr Danny Tsai is an Honorary Research Fellow at the CRE REDUCE and an antimicrobial stewardship pharmacist at Alice Springs Hospital. He is also an academic lecturer and Rural Pharmacy Liaison Officer working at the Centre for Remote Health, a joint centre of Flinders University and Charles Darwin University. 

He has been working in Alice Springs for over 9 years and has a passion for intensive care medicine, infectious diseases and indigenous health. Danny completed his PhD projects in 2017, supervised by Prof Jason Roberts, which focused on improving antibiotic dosing in critically ill indigenous patient with severe sepsis. He has presented at numerous international and national conferences/seminars and has published widely around his PhD research projects and infectious diseases in Central Australia.

In addition to research, Dr Tsai divides his time between responsibilities for preceptorship of interns at Alice Springs Hospital, acts as an accredited Society of Hospital Pharmacists Australia ClinCAT (Clinical Competency Assessment Tool) evaluator as well as an accredited Joanna Briggs Institute systematic reviewer.

 

Publications

·       Tsai D, Jamal JA, Davis J, Lipman J, Roberts JA. Interethnic differences in pharmacokinetics of antibacterials. Clin Pharmacokinet 2015; 54:243-260. 

·       Tsai D, Lipman J, Roberts JA. Pharmacokinetic/pharmacodynamic considerations for the optimisation of antimicrobial delivery in the critically ill. Curr Opin Crit Care 2015; 21(5):412-20.

·       Tsai D, Stewart P, Gourley S, Goud R, Hewagama S, Krishnaswamy S, Wallis S, Lipman J, Roberts JA. Optimising meropenem dosing in critically ill Australian Indigenous patients with severe sepsis. Int J Antimicrob Agents 2016; 48:542-46.

·       Tsai D, Stewart P, Gourley S, Goud R, Hewagama S, Krishnaswamy S, Wallis S, Lipman J, Roberts JA. Piperacillin pharmacokinetics in critically ill Australian Indigenous patients with severe sepsis. Antimicrob Agents Chemother 2016; 60(12):7402-6.

·       Tsai D, Stewart P, Gourley S, Goud R, Hewagama S, Krishnaswamy S, Wallis S, Lipman J, Roberts JA. Pharmacokinetics of total and unbound ceftriaxone in critically ill Australian Indigenous patients with severe sepsis. Int J Antimicrob Agents 2016; 48:748-52.

·       Tsai D, Udy A, Stewart P, Gourley S, Lipman J, Roberts JA. Prevalence of augmented renal clearance and performance of glomerular filtration estimates in Australian Indigenous patients requiring ICU admission. Anaesth Intensive Care 2018;46(1)

 

Conferences/Seminars Presentations:

Optimising meropenem dosing in critically ill Australian Indigenous patients with severe sepsis. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 25th International Conference, Amsterdam, 8-12 April 2016.  

Optimising antibiotic dosing in critically ill Australian Indigenous patients with severe sepsis. Centres of Research of Excellence – Redefining Antibiotic Doses Launch, Brisbane, 29 July 2016. 

Optimising antibiotic dosing in critically ill Australian Indigenous patients with severe sepsis. Alice Springs Hospital grand round, annually since 2016

High risk of underdosing of antibiotics in critically ill Australian Indigenous patients. Medicines Management 43th Society of Hospital Pharmacist of Australia (SHPA) National Conference, 16-19 November 2017. 

Optimising antibiotic dosing in Indigenous patients. National Antimicrobial Resistance Forum (NCAS), PACE, UQ, Brisbane, 2-3 November 2017. 

Health Literacy - A Pecha Cucha presentation. 6th Vital SIgn Multidisciplinary CE event, Alice Springs Hospital, Alice Springs, 1 February 2018. 

Infectious Diseases in Central Australia . SHPA NT/SA Branch CE, Centre for Remote Health, Alice Springs, 18 February 2018.

Infectious Diseases in Remote Northern Territory. PSA CE, Darwin, 17 May 2018